TrialPediatric blood & cancer2019

Determining success rates of the current pharmacokinetically guided dosing approach of topotecan in pediatric oncology patients.

Anna Birg Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.